文献速递脑血管病

既往抗血小板治疗与脑出血结局的关联

Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes.
PubMed 文献 · Stroke · 2017-06-08

结果显示,既往联合抗血小板治疗与院内死亡风险升高相关,而单药抗血小板治疗未见显著差异。

要点

  • 脑出血前联合抗血小板治疗与院内死亡风险升高相关。
  • 单药抗血小板治疗与未用抗血小板者的院内死亡率无显著差异。
  • 既往抗血小板治疗总体与院内死亡仅呈轻度增加关联。

核心结论

  • 在脑出血患者中,既往联合抗血小板治疗而非单药抗血小板治疗,与更高的院内死亡风险相关。

研究设计与样本

  • 患者按入院前未用抗血小板治疗、单药抗血小板治疗和联合抗血小板治疗分组,比较基线特征、合并症、医院特征和结局。

主要发现

  • 诊断脑出血前,65.8%患者未用抗血小板治疗,29.5%用单药,4.8%用联合治疗。
  • 抗血小板组与未用组总体院内死亡率为24%对23%,校正比值比1.05,95%CI 1.01-1.10。
  • 单药组与未用组院内死亡率为23%对23%,校正比值比1.01,95%CI 0.97-1.05。
  • 联合治疗组与未用组院内死亡率为30%对23%,校正比值比1.50,95%CI 1.39-1.63。

临床怎么用

  • 对脑出血患者评估既往抗血小板用药,尤其关注联合抗血小板治疗者可能更高的院内死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Although the use of antiplatelet therapy (APT) is associated with the risk of intracerebral hemorrhage (ICH), there are limited data on prestroke APT and outcomes, particularly among patients on combination APT (CAPT). We hypothesized that the previous use of antiplatelet agents is associated with increased mortality in ICH. METHODS: We analyzed data of 82 576 patients with ICH who were not on oral anticoagulant therapy from 1574 Get with the Guidelines-Stroke hospitals between October 2012 and March 2016. Patients were categorized as not on APT, on single-APT (SAPT), and CAPT before hospital presentation with ICH. We described baseline characteristics, comorbidities, hospital characteristics and outcomes, overall and stratified by APT use. RESULTS: Before the diagnosis of ICH, 65.8% patients were not on APT, 29.5% patients were on SAPT, and 4.8% patients were on CAPT. There was an overall modest increased in-hospital mortality in the APT group versus no APT group (24% versus 23%; adjusted odds ratio, 1.05; 95% confidence interval, 1.01-1.10). Although patients on SAPT and CAPT were older and had higher risk profiles in terms of comorbidities, there was no significant difference in the in-hospital mortality among patients on SAPT versus those not on any APT (23% versus 23%; adjusted odds ratio, 1.01; 95% confidence interval, 0.97-1.05). However, in-hospital mortality was higher among those on CAPT versus those not on APT (30% versus 23%; adjusted odds ratio, 1.50; 95% confidence interval, 1.39-1.63). CONCLUSIONS: Our study suggests that among patients with ICH, previous use of CAPT, but not SAPT, was associated with higher risk for in-hospital mortality.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Khan NI, Siddiqui FM, Goldstein JN, et al. Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes. Stroke. 2017. PMID: 28596454. doi:10.1161/STROKEAHA.117.016290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。